combination

Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer $Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer$

Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer

AETOSWire September 13, 2022

PARIS — Servier, Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., announced today that the investigational combination...

ENJOY A UNIQUE COMBINATION OF FRESH AND PURE AIR

ENJOY A UNIQUE COMBINATION OF FRESH AND PURE AIR

ENJOY A UNIQUE COMBINATION OF FRESH AND PURE AIR

AETOSWire August 3, 2022

DUBAI, United Arab Emirates —Your home’s air quality isn’t as healthy as you think especially during dusty...

True Global Ventures’ Portfolio Company Forge Global Goes Public in Business Combination With Motive Capital Corp

True Global Ventures’ Portfolio Company Forge Global Goes Public in Business Combination With Motive Capital Corp

True Global Ventures’ Portfolio Company Forge Global Goes Public in Business Combination With Motive Capital Corp

AETOSWire March 25, 2022

SINGAPORE – True Global Ventures’ (“TGV”) portfolio company Forge Global Holdings, Inc (NYSE: FRGE) (“Forge”), a leading global private securities marketplace,...